Livforsakringsbolaget Skandia Omsesidigt Sells 50,671 Shares of CVS Health Co. (NYSE:CVS)

Livforsakringsbolaget Skandia Omsesidigt lowered its position in CVS Health Co. (NYSE:CVS) by 83.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 9,882 shares of the pharmacy operator’s stock after selling 50,671 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in CVS Health were worth $444,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the third quarter valued at $25,000. Livelsberger Financial Advisory bought a new stake in shares of CVS Health during the 3rd quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the third quarter worth approximately $31,000. Reston Wealth Management LLC bought a new stake in CVS Health in the third quarter worth approximately $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new position in shares of CVS Health during the 3rd quarter worth approximately $33,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

CVS stock opened at $53.95 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market cap of $67.90 billion, a PE ratio of 13.69, a P/E/G ratio of 0.62 and a beta of 0.61. The business has a 50 day moving average of $50.90 and a 200-day moving average of $56.02. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The company’s revenue was up 6.3% compared to the same quarter last year. As a group, sell-side analysts expect that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.93%. CVS Health’s payout ratio is presently 67.51%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. Evercore ISI raised their target price on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research note on Monday, January 27th. Mizuho dropped their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Piper Sandler cut their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.